• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病前期心血管系统高胰岛素血症与胰岛素抵抗的病理生理学

Pathophysiology of Prediabetes Hyperinsulinemia and Insulin Resistance in the Cardiovascular System.

作者信息

Bkaily Ghassan, Jazzar Ashley, Abou-Aichi Amira, Jacques Danielle

机构信息

Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.

出版信息

Biomedicines. 2025 Jul 29;13(8):1842. doi: 10.3390/biomedicines13081842.

DOI:10.3390/biomedicines13081842
PMID:40868096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12383672/
Abstract

Hyperinsulinemia refers to an elevated level of circulating insulin (80 and 100 µU/mL), often leading to metabolic disorders such as obesity, insulin resistance, and type 2 diabetes (T2D). There is no precise and universally accepted definition of hyperinsulinemia and insulin resistance. The literature in the field remains unclear regarding whether insulin resistance precedes the development of hyperinsulinemia. Recently, a new hypothesis has been proposed suggesting that chronic hyperinsulinemia precedes and causes insulin resistance. The causes of the initiation of hyperinsulinemia, insulin resistance, and type 2 diabetes are multifactorial. Thus, it is not easy to define in general. Recent work demonstrates that the main prediabetic factor leading to insulin resistance is chronic hyperinsulinemia. However, recent work in the literature proposes that relatively long-term hyperinsulinemia does precede insulin resistance and already promotes cardiovascular remodeling. This later may lead to the development of vascular diseases such as hypertension. Thus, defining hyperinsulinemia and insulin resistance, as well as their signaling pathways implicated in the development of type 2 diabetes (T2D), needs to be clarified.

摘要

高胰岛素血症是指循环胰岛素水平升高(80至100微单位/毫升),常导致肥胖、胰岛素抵抗和2型糖尿病(T2D)等代谢紊乱。目前尚无关于高胰岛素血症和胰岛素抵抗的确切且被普遍接受的定义。该领域的文献对于胰岛素抵抗是否先于高胰岛素血症的发生仍不明确。最近,有人提出了一种新假说,认为慢性高胰岛素血症先于并导致胰岛素抵抗。高胰岛素血症、胰岛素抵抗和2型糖尿病起始的原因是多因素的。因此,总体上很难定义。近期研究表明,导致胰岛素抵抗的主要糖尿病前期因素是慢性高胰岛素血症。然而,文献中的近期研究提出,相对长期的高胰岛素血症确实先于胰岛素抵抗,并已促进心血管重塑。这随后可能导致高血压等血管疾病的发生。因此,需要阐明高胰岛素血症和胰岛素抵抗,以及它们在2型糖尿病(T2D)发生过程中涉及的信号通路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfa/12383672/a5c08ca70106/biomedicines-13-01842-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfa/12383672/df005ea004a5/biomedicines-13-01842-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfa/12383672/5b0333a4838d/biomedicines-13-01842-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfa/12383672/35e0b19a964f/biomedicines-13-01842-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfa/12383672/d8f92aa36dfd/biomedicines-13-01842-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfa/12383672/a5c08ca70106/biomedicines-13-01842-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfa/12383672/df005ea004a5/biomedicines-13-01842-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfa/12383672/5b0333a4838d/biomedicines-13-01842-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfa/12383672/35e0b19a964f/biomedicines-13-01842-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfa/12383672/d8f92aa36dfd/biomedicines-13-01842-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfa/12383672/a5c08ca70106/biomedicines-13-01842-g005.jpg

相似文献

1
Pathophysiology of Prediabetes Hyperinsulinemia and Insulin Resistance in the Cardiovascular System.糖尿病前期心血管系统高胰岛素血症与胰岛素抵抗的病理生理学
Biomedicines. 2025 Jul 29;13(8):1842. doi: 10.3390/biomedicines13081842.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Intramuscular diacylglycerol accumulates with acute hyperinsulinemia in insulin-resistant phenotypes.急性高胰岛素血症会导致胰岛素抵抗表型的肌肉内二酰基甘油积聚。
Am J Physiol Endocrinol Metab. 2024 Aug 1;327(2):E183-E193. doi: 10.1152/ajpendo.00368.2023. Epub 2024 Jun 19.
4
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
5
Neurocognition in youth with versus without prediabetes.有与无糖尿病前期的青年的神经认知情况
medRxiv. 2025 Jun 23:2025.06.23.25330130. doi: 10.1101/2025.06.23.25330130.
6
Systemic Inflammatory Response Syndrome全身炎症反应综合征
7
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.糖尿病孕妇持续皮下胰岛素输注与多次皮下注射胰岛素的比较
Cochrane Database Syst Rev. 2016 Jun 7;2016(6):CD005542. doi: 10.1002/14651858.CD005542.pub3.
8
Short-Term Memory Impairment短期记忆障碍
9
The health economics of insulin therapy: How do we address the rising demands, costs, inequalities and barriers to achieving optimal outcomes.胰岛素治疗的卫生经济学:我们如何应对不断增长的需求、成本、不平等现象以及实现最佳治疗效果的障碍。
Diabetes Obes Metab. 2025 Jul;27 Suppl 5(Suppl 5):24-35. doi: 10.1111/dom.16488. Epub 2025 Jun 4.
10
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.

本文引用的文献

1
Pathophysiological Mechanisms of Diabetes-Induced Macrovascular and Microvascular Complications: The Role of Oxidative Stress.糖尿病诱导的大血管和微血管并发症的病理生理机制:氧化应激的作用
Med Sci (Basel). 2025 Jul 2;13(3):87. doi: 10.3390/medsci13030087.
2
Pioglitazone with SGLT2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes and non-alcoholic fatty liver disease: could the combinations of an old friend with new players yield better outcomes?2型糖尿病合并非酒精性脂肪性肝病患者使用吡格列酮联合SGLT2抑制剂或GLP-1受体激动剂:老朋友与新药物联合使用能否产生更好的疗效?
Arch Med Sci Atheroscler Dis. 2025 Mar 14;10:e1-e15. doi: 10.5114/amsad/202298. eCollection 2025.
3
Oxidative stress markers and inflammation in type 1 and 2 diabetes are affected by BMI, treatment type, and complications.
1型和2型糖尿病中的氧化应激标志物及炎症受体重指数、治疗类型和并发症的影响。
Sci Rep. 2025 Jul 2;15(1):23605. doi: 10.1038/s41598-025-05818-z.
4
Neonatal hypoglycaemia in the offsprings of parents with maturity-onset diabetes of the young (MODY).父母患有青年发病型成年糖尿病(MODY)的后代中的新生儿低血糖症。
J Pediatr Endocrinol Metab. 2025 Apr 28;38(6):570-576. doi: 10.1515/jpem-2025-0042. Print 2025 Jun 26.
5
Congenital Hyperinsulinism India Association: An Approach to Address the Challenges and Opportunities of a Rare Disease.印度先天性高胰岛素血症协会:应对罕见病挑战与机遇的方法
Med Sci (Basel). 2025 Apr 1;13(2):37. doi: 10.3390/medsci13020037.
6
Insulin resistance in type 2 diabetes mellitus.2型糖尿病中的胰岛素抵抗。
Nat Rev Endocrinol. 2025 Apr 17. doi: 10.1038/s41574-025-01114-y.
7
In Vitro Chronic Hyperinsulinemia Induces Remodelling of Vascular Smooth Muscle Cells from Young Men and Women in a Sex Hormone Independent Manner.体外慢性高胰岛素血症以性激素非依赖性方式诱导青年男性和女性血管平滑肌细胞重塑。
Pathophysiology. 2025 Mar 13;32(1):12. doi: 10.3390/pathophysiology32010012.
8
The metabolic score for insulin resistance predicts the risk of cardiovascular disease in patients with psoriatic arthritis: results from the 10-year prospective CARMA cohort.胰岛素抵抗代谢评分可预测银屑病关节炎患者的心血管疾病风险:来自为期10年的前瞻性CARMA队列研究的结果
RMD Open. 2025 Mar 7;11(1):e005352. doi: 10.1136/rmdopen-2024-005352.
9
An updated network meta-analysis of non-pharmacological interventions for primary hypertension in adults: insights from recent studies.成人原发性高血压非药物干预的最新网络荟萃分析:近期研究的见解
Syst Rev. 2024 Dec 31;13(1):318. doi: 10.1186/s13643-024-02744-5.
10
Chronically Increased Levels of Circulating Insulin Secondary to Insulin Resistance: A Silent Killer.胰岛素抵抗继发的循环胰岛素水平长期升高:一个隐匿的杀手。
Biomedicines. 2024 Oct 21;12(10):2416. doi: 10.3390/biomedicines12102416.